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IKIROIuailOft.
"(Tumours of the Salivary Gland are a pathological 
puzzle and a source of unsatisfactory speculation."
Bland-Sutton, J., (1906).
Ihis thesis has been composed and written by myself. 
It is a record of the work which was begun whilst in the 
Pathology Department, Southern General Hospital, Glasgow, 
and continued during the tenure of the McIntyre Clinical 
Research Scholarship at the Glasgow Royal Infirmary.
Four hundred and one examples of tumours of salivary
tissue were collected. Of these, 88 presented at the
Western Infirmaiy, and the Southern General Hospital,
Glasgow (1950-55) and the others at the Glasgow Royal
Infirmary (1935-5 6). All the cases were reviewed
clinically and a familiar incidence was encountered on
three occasions. A detailed pathological study was made
3
on the cases seen at the southern G-eneral Hospital, and 
the blood-group of the patients was determined in 341 
cases. In amplification of the pathological study, 
attempts were made to produce salivary tumours experiment­
ally in animals. In vitro studies with radio-active 
sulphur (Sulphur-3 5) were made on 10 consecutive cases of 
human salivary tumour.
The presentation of this thesis is not an indication 
that no further investigations of Salivary Tumours is 
contemplated, but rather that the findings have now reach­
ed a stage beyond which a general survey, such as is att­
empted here, would be unwieldy, and an attempt has been 
made to strike a balance between literary, clinical and 
experimental research.
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PART I.
Review of the literature.
Tumours of Salivary Tissue.
"This bizarre lesion......M
Furst enburg, (194-1).
Since the first attempt by Berard (184-1), tumours of 
salivary tissue have not been satisfactorily classified 
either clinically or pathologically. Attention has been 
focused mainly on the so-called "mixed tumours", and the 
other varieties have often been neglected.
The term "adenoma" was introduced by Lebert & Broca 
(1850) for benign tumours of the Parotid gland, and most 
writers consider them as only a variant of pleomorphic 
adenomata, namely the most slowly growing and innocous 
variety. According to Willis (1953) pure adenomas are 
slowly growing, encapsulated, lobulated epithelial tumour 
and there is no sharp line of demarcation on structural 
grounds between simple adenoma and pleomorphic adenoma. 
Some n4-0 cases have been described in European Limr^ ,ui.
"fciie first in British literature was by Dunlop (1879) in •?,
3 6 . year old female patient at the G-lasgow Royal Infirmary. 
Only a few American workers, (Schutz, 1926; McFarland,
1927; Slaughter et al, 1953 and Ross, 1955) have reported 
cases; it is interesting to note that McFarland (1936) 
later reports that the ease he described originally as s. 
true simple adenoma was in fact a pleomorphic adenoma,
Eggers (1928) classifies two of his seven pkatal tumours
h
as adenomata.
Pleomorphic Adenomata.
The vast majority of salivary growths are pleomorphic 
adenomata., the so-called mixed salivary tumours - a term 
dating from Minssen’s report in 1874* Although the 
first published reports of such tumours are generally 
credited to C.G-. Siebold (1793) and J.P. Siebold (1797)? 
little of morphological interest has been added since it 
was first recognised as a clinical entity in 1853 by pegeo.
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The first complete record end review of the 1 iterature was 
"by Wood (1904) and subsequent reviews of note were under­
taken by Wilson & Willis (1912); Heineke (1913); Kennon
(1921), and McFarland (1926, 33, 36, 42, 43). Swing (1940)
C -
states that "no simple source of mixed tumours meets all 
the requirements'1, while Pick (1909) and Patey (1931) 
rightly suggest that confusion over terminology has been 
due to its uncertain aetiology, and such hyphenated 
monstrosities as chondro^myxo-haemato-endothelio-sarcoma 
have been used.
Originally, most of the German pathologists considered 
them of connective tissue origin, and any epithelial 
structures as vestiges of the gland in which they occurred. 
Billroth (1859), Virchow (1863) and Kaufmann (1929) were 
of the opinion that they were of mesenchymal origin, while 
Waytmann (1879) expressed the opinion that they were 
derived from lymphatic endothelium. Volkmann (1695) 
thought he bad nroved the endothelial origin as did raa .a.
was, however, adversely criticised by Hinsberg (1899), 
Cuneo u Veau (1900), Wood (1904), Chevassu (1910) and 
Ssobolew (1912) who suggested a branchio/genic origin, 
which was origihally suggested by Cohnlieim (1876) and 
Birsch-Kirschfield (1894). This theory would explain 
the presence in some tumours of areas of "cartilage"and 
"bone”. Wilms (1899) and Marchand (1910), together with 
others, regarded them as composite tumours in which the 
epithelium plays the most important part, and traced them 
to an origin analagous to that of teratomata, except that 
the embryonic rudiment is separated at a later stage. 
Pitance (1897) thought that some developing buds were 
broken off and detached in the later development and form 
the nucleus of a tumour. Other suggested theories at 
this time include that of Forgue <1 Massabuau (1908) that 
they should be classified as embryomata along with 
testicular tumours. Teratomata of the neck have been
■by Thomas (1957) and Edwards (1958), hut these are quite 
different. Another theory which did not get many
K
supporters was that of Krompecker (1908) who regarded th 
as basal cell tumours.
Fraser (1918) with his work on dogs believed he hed 
experimental proof that they arose from the ducts of adu 
glands. McFarland (1926) supported by Kux (1931) and 
Hempleman and Womack (1942) suggested that the origin wa 
probably sequestration of embryonal cells, this was in 
agreement with Forman and Warren (1918). Many agree on 
the pure epithelial nature of tie tumours - Fick (1909);
M
Bottner (1921); Fry (1928); Patey (1931); Zymbal (1933); 
Harvey et al (1938); Muir (1941); and others who have 
accepted without question the belief that they contain 
"cartilage", have devised various explanations as to tie 
origin of the "cartilage". Harvey et al (1939) suggest
in a retraction space in the acellular homogeneous mucoid 
matrix giving all the appearances of cartilage cells 
within their capsule. Pry (1928) suggests that a simile, 
appearance is giveh hy a ring of deeply staining mucin 
round isolated cells.
By far the majority of pleomorphic adenomata arise 
in the parotid gland, less commonly in the submandibular, 
and rarely in the sublingual gland* They are, however, 
also found in the palate and various parts of the oro­
facial region such as the lips, nose, pharynx or lacrimal 
glands; arising probably from serous or mucous glands. 
Submandibular tumours have been specially considered by 
Ohevassu (1910) and Dockerty & Mayo (1942), while Paget, 
3. (1886); Sggers (1928); D'Aunoy (1930); Davis (1935) 
and Stobie (1935) have discussed palatal tumours.
Lacrimal aland tumours were considered b;/ V erhoeff v 15o o
and those of the lip d Paget, <j. (1651) and more recently 
by Bernier (1946).
The commonest age of first appearance of the tumour
V. ? (Swv
is "between the third and fourth decade, hut no age is 
exempt. Byars et al (1957) state that 5$ occur before 
the age of 18 years, white McFarland (1926) considered 6b 
occurred before the age of 40 years and 90fo before the ape 
of 50 years. Occasionally the condition is first 
encountered in infancy; Pailler (1903) reported a case of 
a mixed tumour in a child of eleven months and Wood (1904) 
in an infant of seven months. Examples reported appearing 
in the first decade of life include Chevassu (1910) and 
Zymbal (1933) at 9 years; and Pry (1928) at 10 years. 
Schilling (1921) reported a case occurring in a 41 year old 
man that had been present since he was 1 year old.
McFarland (1942) out of 380 cases found 8 occurring in the 
first decade. The tumours exhibit a slow imperceptible, 
intermittent growth and the shortest reported duration
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before operation was G months (Bland-Sutton, 1906). are 
longest periods recorded prior to operation vary from 40-GO 
years in the cases reported by Street (1913) and Ross (1955 
respe ctively.
Although in recent years, most reported series show a
predominance of females, most earlier workers stated that
the sexes showed little difference in their liability to
pleomorphic adenomata of salivary tissue. In spite of
the literature being mainly of European and American cases,
they have been reported to occur in Chinese (Balme, 1912 and
Yen, 1915); and in Hindus (Davidson, 1910 and Street, 1913) 
while McFarland (1942) reported seven in black-skinned
people. Hickey (1957) considers pleomorphic salivary
adenomata of the palate and tongue relatively common in
Sudan.
In some cases, gross deformity has been produced yet
the host shows little ill-effect. According to Heister
(1739) he had never met any directions for the removal of
i-3
the parotid or submaxillary glands, though 
these glands indeed "frequently indurated and 
enlarged to a monstrous size"* Eemoval of 
the tumour was considered dangerous and 
unjustified, often the patient refused surgery 
as in Cotterillrs (1907) case ^ Fig.1), which has 
been regarded by McFarland (1943) and others as 
the largest tumour recorded. The reported 
weight of 26 lb. was only an estimate, as the 
patient refused operation. As these tumours 
have in the past received only a passing mention, 
details were often scanty and the weight, when 
it was mentioned, was not necessarily accurate. 
Witness Keen's (1904) case which was said to
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Fig. 1.
Photograph of Cotterill's case.
(by permission of the 
publishers, W. Green 1; Son,
Ltd. , Edinburgh).
be 71b.; the excised tumour weighing only 4flb. at 
operation, but an allowance was made of 21b. for the fluid 
lost when the tumour was "burst” a year before the 
operation. Amongst the largest surgically treated and con­
firmed histologically as "mixed" are those shown
in the following Table. The case of
15
31. ort 1 Puller (1955) is included in this series (5e.se 
as she had been treated at the Glasgow Royal Infirmary 
between 1935-56.
TABLE Vi.
Other giant parotid tumours classified histologically as "mixed".
AUTHOR. WEIGHT. SIZE. SEX. AGE at DURATION
onset. in years.
Spence,(1863). 3.1 kg. 9J x 8f x 7f 
inches.
E. 18 16
Ronville & Martin.
(1904)
2.95 kg. P. 14 30
Ahlbom,(1935)• 2.25 kg. P. 30 17
Prazell,(1954)• 1.27 kg. 22 cm. diam. P. 38 6
Cade,(1954). 1.99 kg. 19 x 15 x 13 
cms.
M. 54 18
Short & Puller,
(1955).
2.8 kg. 30 cm. diam. P. 33 16
Opinions vary slightly as to the recurrence rate, for 
example, Wood (1904) quotes 30$; Benedict <1 Lleigs (1930-) 
42.5$; Stein & Geschickter (1934) 20$, and McFarland (1942) 
25$. Such recurrences are more frequently encountered in 
parotid tumours, probably because of anatomical relations 
(Prfcey, 1940).
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■ Carcinomata,
There is often no sharp line of demarcation 
between an unusually active pleomorphic adenoma and a 
frank carcinoma* As Pry (1928) suggests, however, there 
are varying degrees of malignancy and that the incidence 
is higher than is generally appreciated, reports varying 
from 10-iC?^ * On an average, according to Foote &
Prazell (1954), the age incidence is 10 years older than 
in pleomorphic adenomata, while Quattelbaum et al (1946) 
give the average age as 49*8 years. Lick (1954), 
however, reported a case of a small cell carcinoma aris- 
ihg in the left cheek of a two day old boy*. Like other (  ^
tumours of Salivary tissue, the parotid gland is the 
commonest site (Sirsat, 1953), followed by the sub­
mandibular and sublingual glands - the palate being an
intermediate site* As a rule such cases are unilateral 
and apparently malignant from the onset, the growth
being accordingly more rapid and there is a snorter
malignant salivary tumours there appears to be no 
preference for side, and there is little difference in 
the sex distribution as reported by previous workers. 
According to Redon (1953), less than IQfo survive 5 years 
after receiving treatment.
Unlike other salivary tumours, the features of 
Salivary Carcinomata appe ars/Co be perineural involvemen 
with pronounced infiltration (Bauer & Fox, 1945; 
Quattelbaum et al, 1946). So pain and paralysis are 
common features as is ranid increase in size. Accordint
to Ross (1955), pain is a feature in 50fo and 2 5b show 
severe paralysis. The capsule^ of the tumour can rareL 
be separated from the underlying tissue and they are oft 
fixed to the skin. Ketastases do occur," 5 Oj^McFarland 
(1942) 13 fatal cases, and 5 of 8 fatal cases in 5 years 
ciuoted by Quattelbaum et al (1946), showed pulmonary
Salivary A d enu 1 yinohoraat a.
Salivary adenolymphomata are a class^unto themselves; 
various names have been applied to them including among 
others, papillary cystadenoma lymphomatosum, branchiogenic 
cystadenolymphoma, oncocytoma and Warthin's tumour. They 
were first reported by Iiindelbrandt in 1898 but were only 
established as a distinct morphological entity in 1910 by 
Albrecht <1 Arzt, being_oompoaed mainly of epithelial and 
lymphoid tissue in or near the parotid gland. Nicholson 
(1923) reported the first case in British literature.
No case, according to Carmichael et al (1935), has been 
correctly diagnosed before operation; this statement, /’yg q ^ .  
however, is inaccurate, as some can be diagnosed correctly.
As with pleomorphic adenomata various theories as to
their origin have arisen. Noteworthy one being
'’branehiogenic - suggested by Ssobolew (1912) and supported
by others, although not in vogue to-day. Another
suggested by Warthin (1929), after whom the tumour is
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is sometimes called, is that they arise from the epithelium 
of the embryonical pharyngeal entoderm or the upper 
respiratory tract displaced to the region of the parotid 
gland* Among those supporting this theory are uaston & 
Tedeschi (1946), hawson & Horn (1950), nobinson & narless 
■(1943) and hraissl & otout (1933)* A third more acceptable 
theory, originally postulated by Albrecht Arzt (1910) and 
recently supported by Harris (1937) and Martin and jihrlich 
(1 9 4 4) is that they represent heterot^opic salivary gland 
rests situated in lymph glands adjacent to or in the parotid. 
Jaffe" (1 932) pointed out that such tumours are usually 
situated on the external surface of the gland although the 
capsule of the tumours may fuse with the capsule of the gland. 
He regarded lymph tissue as not an essential part of the 
tumour but merely as a remnant of a lymph node. let 
another theory was recently postulated by Thomson & Bryant 
(1 9 5 0) who made an extensive study of the subject, includ­
ing detailed examination of human embryos; normal 
human salivary glands; branchiogenic cysts,
sihub es and 23 tumours* On their findings they relate 
the uumours to "neoplastic proliferation of the parotid
f
ducts included in lymph glands". Haiherl (1931) suggested 
the oncocytes as the site of origin, hut Ackerman (1943) 
considered oncocytomata as a different entity from 
adenolymphomata. Meza-Qhavez (1949), however, showed 
the occurrence of oncocytes in normal parotid glands - 
heing found in 9 out of 100 glands from 51 person^
Adenolymphomata afe rarely found in sites other than 
the parotid gland (Plaut, 1942). A few bilateral cases 
have been reported (Nino, 1940; Oughterson, 1941; Ramage 
et al, 1943; Lederman, 1943; Martin & Ehrlich, 1944; 
Lawrence & Procita, 1946; Foote & Prazell, 1953, and 
Schulenberg, 1954). They occur at any age, but are 
generally encountered in the s eventh decade* Plaut 
(1 942) gives the figure as 84^ occurring after the age of 
40 years. The youngest case recorded is in a boy aged 2h 
years (Stohr & Risack, 1926) and the oldest in a man aged
92 years (Carmichael et al, 1935). Most previous 
workers have shown a decided sex difference; it being 
more common in femail* patients. A few malignant cases, 
have been recorded, (Ssobolew, 1912; Stohr & Risaek, 1926 
Lederman, 1943; Lloyd, 1946; and Gaston & Tedeschi, 1946) 
otherwise recurrences are rare.
Miscellaneous Tumours.
Numerous other salivary tumours, reputed to have 
arisen in or adjacent to the Salivary glands have in the 
past been classified as sarcomas. Other less common 
tumours include
a), n euro fibromata (McFarland, 1926; Wheelock &
Maddtn, 1949),
b). lipomata (Lockerty & Mayo, 1942),
c). angiomata (McFarland, 1926; TWheelock Sc Maddin, 1949
d). rhabdomyomata (Prudden, 1883; Wood, 1904),
e). leiomyomata (Wheelock & Maddin, 1949),
f). lymphangiomata (Kennon, 1921; Wheelock Sc Maddin, 194
g). malignant melanomata (Rodriquez, 1889; Gilis & 
Godlewski, 1905 and Haggard, 1919).
Iiaemangiomata, however* deserve brief comment -
usually of the hypertrophic variety and found in infants
'22
dr children, the commonest cause of chronic unilateral 
A
parotid swelling in the first year of life.
Treatment
Tumours of salivary tissue are either potentially
1 malignant, borderline, or definitely malignant (Ross,1955), 
*
| and should, therefore, not he neglected. Patey (1940)I* suggested that there should he no hurry to operate and
^ that the pre-operative period should he used to observe 
v
and determine the rate of growth and the presence or 
absence of pain or paralysis. Sialography has not in 
the past been used very extensively, but careful study 
of radiographs does add another very worthwhile, yet 
unessential, pre-operative examination. A concise 
portrayal of the method is given by BXady & Hocker 
(1938-9).
Minor operations such as enucleation are inadequate 
and should he condemned, while biopsies are generally
considered, howadays, as just meddlesome surgery.
23
ove
of tumour cells implanted in
indicated by scar formation
. J
24'
v. V  •>>»••/. -\‘j•*a\ at h-1
Pig. 2. (above) shows a nest 
of tumour cells implanted in 
a needle tract. The dotted 
line is the needle tract, as 
indicated by scar formation 
and recent healing. Pig* 3 
(left) E.P. cell nest.
(by kindness of Dr. Ackerman 
and also the photomicrographs)
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A.l i> ::u u;5- g relimi o.ar,y uiupmi. :.;a ary advocated oy By arc et 
al (19J7), they demonstrate (figs, 2 & 3) Bow a nest of 
tumour cells can become implanted in a needle tract of ::n 
aspirated biopsy. These "key-hole" operations, besides 
being inadequate, tend to spread the tumour cells and 
make a recurrence almost a certainty. Parotidectomy is 
replacing enucleation a s the standard treatment of 
salivary tumours - partly because of the belated 
recognition of the frequency of infiltrating types which 
cannot be removed by enucleation due to satellite tumours 
closely associated with the larger one (Fitzgibbon, 1953)- 
suggestive of multi centric origin. Parotidectomy was 
established in the 1940fs as the routine treatment for 
parotid tumours by Janes, (1940); Bailey, (1941); and 
Bedon, (1953 & 5). Janes (1957), rather than accept the 
multi cent ric origin theory/- for multiple recurrence, 
considers them due to Mseeding of the wound uhrough
runture of the tumour capsule'1.
25
fear of damage to the facial re rve (Patey, 1940). A 
paralysed face is a real calamity and a very difficult 
fact to explain to a patient, especially those who 
appeared to have only a molste/ble nodule prior to surgery, 
hut which, in fact, are only the "top of the mountain1' 
(Boss, 1955), such dumh-bell tumours are described by 
Proby (1924); Leriche (1935) and Patey (1957). Due to 
the extremely low recurrence rate of the French workers, 
Redon <1 Belcour (1955) and Moyse (1955), the case for 
routine superficial lobectomy is strong. Holmberg & 
Glover (1951) state that surgical excision is the correct 
form of treatment, as the majority of salivary tumours 
are radio-resistant (Patey & Thackeray, 1954). Radio­
therapy is, however, of value pre-operatively (Patey,1940 
to toughen up the capsule. It is also used beneficially 
post—operatively, but according to most its record as 
the sole form of treatment is Pi Of convincing.
PART II.
Clinical material and results of investigations.
Clinical Review.
The classification of salivary tumours used through­
out this thesis is a modification of that of Willis (1953), 
and the classification along with the number of cases is 
shown in the following table.
T A IU .L  I I , -  l I \SS1KK ATION OP S A L IV A R Y  TU M O U R S
IY 1 T No. • %
I Simple Adenoma - -
I I P leom orphic Adenoma 315 78 .5
I I I Carcinom a 64 16.0
IV Adenolymphoma 16 4.0
V M iscellaneous 6 1.5
T O T A L 401 100
The distinction between simple adenoma and pleomorphic 
adenoma is so artificial that the first two types can be 
grouped together. Not a case was found which could be 
classified wholly as a simple adenoma. With this in mind,
only the last four types of salivary tumour will be 
considered. 28
Pleomorphic adenomata,
There are in this series 315 examples of pleomorphic 
adenomata, constituting 78.5$ of the total. By far the 
majority of them arise in the parotid gland, less commonly 
in the submandibular, and rarely in the sublingual. The 
site distribution reported by several workers is contrasted 
with the present series in the following table.
TABLE III.
Showing the site distribution of 315 pleomorphic salivary adenomata as compared 
with that of previous workers.
Author. Parotid. Submandib. Subling. Palate. Lip. Mi sc. Total.
Present series. R. 142 8 0
14 9 7 315
L. 123 II i
Total. 265 19 i 14 9 7 315
Wood,(1904) • 35 13 0 3 4 4 59
Shreiner & Mattick,(1929) .45 7 0 I 9 4 66
Patey,(1931). 38 6 I 5 I 3 54
Zymbal,(1933). 55 2 0 0 I 0 58
Harvey et al,(I938). 230 21 2 6 9 7 275
Willis,(1953). 35 6 I 5 I 0 48
Ross,(1955). 84 9 0 3 0 2 98
t will be seen that the parotid gland accounts for just
over 80$ of such tumours. Other series vary from 70$ 
(Sirsao, 1953) to 98$ (kontella & Pont ana, I95t>). Of
cases (53 *6/0 occurred on the right side - this slight 
preference for the right side, although not statistical, 
agrees with the findings of Wilson & Willis (1912) and 
Benedict & Meigs (1930); while McFarland (1943) states 
that the left is more frequently involved. From these 
findings there would oe apparently no preference for any 
side.
The commonest age of first appearance of the tumour 
was between the third and fifth decade; almost bO$ occurr­
ed before the age of 40 years and 90$ before 60 years of 
age. Table IV shows the decade distribution of the age 
at the first appearance of the tumour in the cases in this 
series* Of the four occurring in tne first decade, the 
earliest age of first appearance was 3 years of age, being 
treated conservatively until 42 years of age* The remain­
ing three all appeared at 9 years of age with surgery being 
undertaken 3, 4, and 5 years later, respectively. Most
tumours exhibited a slow, intermittent growth and on an
30
Table M I V
Shows the 
of the tumour
decade
*
distribution of the age at first appearance
Decade. I 2 3 4 5 6 7 8 9 10 Total.
Kale • I 17 20 34 21 15 9 5 I 0 123
Female. 3 21 41 46 40 26 12 2 I 0 192
Total. 4 38 61 80 61 41 21 7 2 0 315
Table £V.
Shows the decade distribution of the age at the time of the 
first operation. This Table should be compared with the previous 
Table, in order to determine the rate of growth.
Decade. I 2 3 4 5 6 7 8 9 10 Total.
Male. 0 10 17 27 28 18 13 9 0 I 123
Female. 0 9 34 35 41 49 14 9 I 0 19 2
Total. 0 19 51 62 69 67 27 18 I I 315
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average b years elapsed from the time of first appearance 
until the initial operation. Table V shows the decade 
distribution of the age at the time of the first operation 
in this series. The longest duration before being subject­
ed to surgery, was, in this series, 39 years. There would 
appear to be a predominance of females in the 315
TABLE Vi.
Shows the s e x distribution of the 
pleomorphic adenomata in the present 
series as compared with the figures 
given by previous workers.
Author. Male. Female.
Wood, (X904) 25 21
Chevassn,(1910) 30 27
Wilson & Willis,(1912) 30 26
Bottner,(1921) 10 15
Fry,(1926) II 14
Atilbom, (I9S5) 106 148
McFarland,(1942) 184 212
Willis,(1953) 16 34
Fitzgi'b'bon, (1953) 19 23
Present series, 123 192
cases of pleomorphic adenomata. The figures of previous 
workers, together with the present series, are seen in 
Table VI. Although most of the patients were British, 
two were Hindus. The largest tumour met with in this 
series was that reported By Short & Puller (Case No.22i), 
included here because she was treated at the Glasgow Royal
Pig.4. Photograph of the largest tumour 
met with in this series.
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Infirmary between I935~5b. Hie recurrence rate was 
29 •!?/&, and details of th.ese recurrences together with
TABLE VII.
Shows the recurrence rate of Pleomorphic Adenomata at 
their sites of origin.
Parotid. Submandih. Subling. Palate. Lips. Misc. Total.
Recurrences 78 7 I 2 I 4 93
Non-recurrences 187 12 0 12 8 3 222
Total. 265 19 I 14 9 7 315
their sites are seen in Table VII. The average time 
interval between the original operation and subsequent 
excision in this series was 4 years. These tumours must 
be differentiated from tuberculosis, actinomycosis, and 
chronic adenitis due to oral-aural sepsis (Boyd,1938). 
Most can diagnose with a fair degree of accuracy a 
salivary tumour, but to differentiate salivary tumours
among themselves is probably an almost impossible task
before operation* All such tumours, however, should be 
looked upon as malignant or potentially malignant until 
proved otherwise*
Not one reference was found of any previous report of 
pleomorphic adenomata affecting more than one member of a 
family. Yet, in the present series, familial incidence 
was found on three occasions*
A. On 2/9/52 a man aged 51 years presented at the 
Southern General Hospital with a left-sided sub­
mandibular tumour of 1 year's duration which was 
excised. Histology of the tumour tissue showed
fig.5. Photomicro­
graph of the father's 
tumour.
(HxE. x 50).
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epithelial islets in a myxomatous stroma, witii 
extensive areas of squamous metaplasia (Pig.4).
He died on 11/8/54 having had, in the interval, 
two recurrences with the same histological 
picture. On 3/4/53 his 21 year old son presented 
with a left-sided parotid tumour of two years
fig.5.
Photomicrograph 
of the son’s 
parotid tumour. 
(H. and E, x 50).
duration. Histologically the tumour had the 
appearance of a typical "mixed" parotid tumour 
(Pig. 5). He has had, to date, no recurrence. 
The daughter ^ when aged 21 years had, on 6/12/55, 
a right-sided parotid tumour excised, after it 
had been present for two years. This tumour 
showed a typical pleomorphic adenoma with a pre­
dominance of matrix and relatively few
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Pig. 6.
Pho t omi crograph 
of the sister’s 
tumour.
(H.and E. x 50).
epithelial elements (Pig.6.)
B. A 21 year old man was seen in December 1956 at 
the Glasgow Royal Infirmary with a recurrent 
right-sided parotid tumour. Previous excision 
having been on 30/7/49 when it was reported as 
a typical pleomorphic adenoma. Subsequent 
excision in January 1957 revealed a more cellular 
pleomorphic adenoma (Dr. A. Currie). It was noted 
that his father (54 years old) had a right-sided 
parotid tumour of 12 years duration. Pie has, to 
date, refused operation, but clinically the diag­
nosis is without doubt (Prof. W. A. Mackey).
C. At the follow-up of this series a 25 year old 
married woman was seen at the Glasgow Royal 
Infirmary in December 195b, where, on 23/4/47 she
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had had a tumour excised from her left parotid 
region, having been present for the previous 
2 years* This tumour had been reported as a 
typical "mixed" parotid tumour with extensive 
areas of myxomatous stroma. When seen in
December 1956 she had no sign of any recurrence
and volunteered the information that her 50 year 
old mother had had a "lump" removed from the left 
side of her face when 18 years of age, somewhere 
in England. She had been told that it was likely 
to recur as it was a "mixed cyst of her saliva 
glands". To date, however, there has been no 
recurrence.
In Table VTII it is seen that in family A there is
histological proof in all three cases (Dr. A. Dick).
FA M IL IA L  IN C ID E N C E  OF “ M IXED SA LIVAR Y TUMOURS”
a. Father aet 51 — 2. 9. 52 ' ‘ — Mixed submandibular tumour
Son aet 21 — 3. 4. 53 — Mixed parotid tumour
Daughter aet 21 — 6. 12. 55 ' — Mixed parotid tumour
b. Father aet 54 — 3. 12. 56
Son aet 14 — 30. 7. 49
•c. Mother aet 18 — 1924 in  England — “ Mixed cyst of Saliva Gland*9
Daughter aet 16 — 23. 4. 47 . — Mixed parotid tumour
— C lin ica l Mixed parotid tumour
— Mixed parotid tumour
In "B" clinical observations must be relied upon since the 
father prefers, in the meantime, to retain his tumour; 
while in family C, the history of pelomorphic adenoma in 
the mother is so circumstantial as to be almost certainly 
valid.
Carcinomata.
There will be seen from the following two tables that 
the age incidence at the time of first appearance of 
salivary carcinomata is between the fifth and eighth decade. 
In view of the more rapid increase in size and the assoc­
iated symptoms of pain and/or paralysis, there is a shorter 
interval before the patient received treatment - in this 
series 2-3 years on an average.
In no case in this series was bilateral salivary 
carcinomata diagnosed, and like other tumours of salivary 
tissue, the parotid gland was the commonest site, followed •
submandibular gland, palate and one in each of the
TABLE IX.
Shows the decade distribution of the age at the onset of
Salivary Carcinomata.
Decade. 1 2 3 4 5 6 7 8 9  10 Total.
Male • I 3 2 I 8 9 7 7 I 0 39
Female. I I 3 0 3 5 8 4 0 0 25
Total. 2 4 5 I II 14 15 II I 0 64
TABLE X,
Shows the decade distribution of the age at the time of the 
first operation for Salivary Carcinomata. To be compared with 
Table IX, in order to determine the rate of growth.
Decade. I 2 3 4 5 6 7 8 9 10 Total.
Male. 0 I I 3 5 10 9 9 I 0 39
Female. 0 2 0 2 I 5 9 6 0 0 25
Total. 0 3 I 5 6 15 18 15 I 0 64
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following sites, the sublingual gland, nose, tongue, ana 
lip. This is shown in Table XI which also shows that in 
this series there would appear to be no preference for side 
in salivary carcinomata.
TABLE XII.
£21ows the sex distribution of Salivary Carcinomata in this seties at their 
sites of origin.
Parotid. Submandib. Subling. Palate. Lips. Nose. Tongue. Tot al.
Kale. 27 6 0 5 0 1 0 39
Female. 20 I I I I 0 I 25
Total. 47 7 1.......6 I I I 64
TABLE XI.
Shows the site distribution of Salivary Carcinomata. 
Parotid. Snbmandib. Subling. Palate. Lips. Nose . Tongue.
Right. 24 3 0
6 1 1 I
Left. 23 4 I
Total. 47 7 I 6 1 1 I
In malignant salivary tumours there appears to be a slight 
predominance in males - this difference in the sex distri­
bution does not appear to have fteen so marked in previous 
reviews. (Table XII).
41
As will be seen in Taole XIII, recurrences were noted m  
58 of tlie 64 cases and in the remainder, death had occurred 
in 4 very shortly after operation due to other causes,
TABLE XIII.
Tfiis Table shows the recurrence rate in Salivary Carcinomata in 
relation to the site of origin.
Parotid. Submandib. Subling. Palate. Misc. Total.
Recurrences. 41 5 I 6 3 58
Non-recurrences. 6 P. 0 0 0 8
Total. 47 7 I 6 3 64
In 4 of the 8 non-recurrences, death occurred shortly after the first
operation due to natural causes.
The incidence of salivary carcinomata is much higher 
than is generally appreciated - in this series it accounts 
for 16$ of the total of salivary tumours. Various reports 
of previous reviews, together with the present value, is
given in Table XIV.
TA B LEXiV jg l
Showing the percentage incidence of 
Salivary Carcinomata.
Nasse,(1892) 11$.
Wood,(1904) 25f.
Kennon,(1921) 2 a£.
Benedict & Meigs,(1930) 42f,
Stein & Geschi^/llr, (1934) 15f.
Slaughter et al,(1953) 26 f.
Ross,(1955) 22.8 fo.
Present series, 16 fo.
Ad enolymphomat a.
They occupy about 4$ of the salivary tumours in
this series and are a clas^^nto^^e ms elves. Unlike
Carmichael et al (1935), three at least of these tumours
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wei*© caagnosed correctly oeiore operation, A H  but one 
of the 16 adenolymphomas occurred in the parotid gland, 
the one abstainer occurred in the right tonsil* In this 
series bilateral adenolymphomata was found in four cases - 
of the remainder 7 occurred in the left parotid and 4 in 
the right parotid gland* The finding of previous workers, 
that they were commoner in females was not shown in this 
series (Table XV)*
TABLE XV#*
Shows the sex- ratio of Adenolymphomata in the present series as 
compared with that in previous reviews.
Author. Female. Male • Ratio.
Carmichael et al,(I935). 24 4 6:1
Plant, (1942). 50 12 9: 2
Martin & Ehrlich, (1944). 20 2 10:1
Gaston & Tedeschi,(1946). 73 17 9: 2
Lloyd,(1946). 5 I 5:1
Hevenor & Clark,(1950). 19 I 19:1
Present series, 8 8 1:1
Hot a single case was found in the first three decades of
TABLE XiVt
Shows the decade distribution of the age at the first 
appearance of Adenolymphomata*
Decade• I 2 3 4 5 6 7 8 9 10 Total.
Male* 0 0 0 I I I 3 2 0 0 8
Female* 0 0 0 2 I 2 I 2 0 0 8
Total* 0 0 0 3 2 3 4 4 0 0 16
TABLE XVII,
Shows the decade distribution of the age at the time of 
the first operation for Adenolymphomata.
Decade• I 2 3 4 5 6 7 e 9 10 Total.
Male. 0 0 0 I I 0 3 2 I 0 8
Female. 0 0 0 I I I 3 2 0 0 8
Total. 0 0 0 2 2 I 6 4 I 0 16
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life, in this series. The age distribution at the onset 
and at the time of first operation is shown in Tables 
XVI and XVII. There was no recurrence noted in any case 
to date, and no case was reported as malignant.
Miscellaneous Tumours*
In this series, only six tumours were included to 
come under this catergory* They included two melanomas, 
two reticulum cell sarcomas, a recurrent leiomyosarcoma, 
and a fibroma. Recurrences had occurred in all but the 
fibroma, and death had occurred in all the patients 
before the follow-up was possible.
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Histological Review.
Reference has already been made to the varied 
structure of pleomorphic adenomata and now only the 
commonest variations which were encountered will be shown. 
The findings recorded in this section accord with the 
descriptions of earlier workers, in particular of Zymbal 
(1933) and of Willis (1953); the former giving by far the 
best account of the microscopical structure of salivary 
tumours.
In some tumours, many or all the possible variations 
of structure may be found in close juxtaposition with all 
gradations between them; while in oxhers, one or anotner 
structural variant predominates. The following types of 
structure will be described in turn:-
a). normal salivary tissue,
b). atypical glandular tissue with or without 
epithelial sprouting,
c). solid epithelial formation,
d). epithelial masses with cystic spaces,
e). cornifying squamous metaplasia,
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f). variations in the proportions of the epithelial 
elements and the matrix, and finally,
g). areas of ’pseudo-cartilage” .
a) Normal salivary tissue.
Salivary glands are termed compound racemose glands,
consisting of numerous lobes, which are made up of lobules,
connected together by dense areolar tissue, vessels and
ducts.
Fig*7. 
Photomicro­
graph of 
normal saliv­
ary tissue. 
(H.andE.x 100).
Each lobule consists of a ramifaction of a single duct, the 
branches ending in slightly dilated ends and alveoli on 
which the capillaries are distributed. The alveoli of 
salivary glands are of two kinds, mucous and serous. The
cells of the mucous alveoli are columnar in shape and the 
nucleus is usually situated near the basement membrane 
and is flattened. The cells in the serous alveoli fill 
the cavity almost completely in the resting condition.
The cells are more cubical and the nucleus is spherical 
and central in position. The ducts are lined at their 
origin by low cubical epithelium, but as they enlarge 
the epithelial cells change to columnar type; near the 
opening into the mouth the epithelium becomes stratified. 
The photomicrograph (Fig.7.) shows a typical normal 
salivary tissue.
b). Atypical glandular tissue.
This is seen in a great variety of forms. They 
may be acinar or ductular in type; cystic or papillary; 
and they may contain mucoid or hyaline material. Pre­
dominance of the goblet-cell epithelium is sometimes seen 
as in the cases of, Schilling (1921), Lepp (1939), Pe & 
Tribedi (1939), Skorpil (1940), Linell (1948), and Gooray
fa
et al (1950). On occasions it is associated with squamous- 
cell epithelium and some workers believe such tumours to 
form a distinct group of "muco-epidermoid” tumours and 
state that they account for approximately 50$ of salivary 
tumours. Stewart et al (1945) found 45 cases out of 70u 
salivary tumours; the site of origin would appear to be 
in the salivary ducts. Hartz (1946) was the first to 
describe such a tumour accurately. Foote & Frazell (1954) 
rather than subdivide them into benign and malignant, use 
the terms high and low grade malignancy. They found 51 
low-grade and 47 high-grade tumours out of a total of 900 
cases (1929-49)• According to Du Plessis (1957), in 28$ 
of normal parotid glands sebaceous glands may arise from 
the parotid ducts, thus explaining the site of origin of 
such ’muco-epidermoia” tumours.
The classical 'ductular type is seen in Fig. 8 ., while 
a relatively common pattern (Figs.9 & 1 0 ) is that in which 
the glandular tissue merges into the mucinous matrix. This
5 0
Pig. 8.
Pho t omi c ro graph, 
showing a 
glandular type 
of pleomorphic 
adenoma.
(H.& E. x 100).
finding is well described by Zymbal (1933), ana is shown 
by epithelial sprouting from the glandular formations. 
This fraying out of the epithelium is a common way of 
development of the so-called "mucoid tissue".
-Vi.'
Pigs. 9 & 10 Olandular tissue merging into mucoid matrix, 
n. & E. X 50 H. & E. X 100
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A feature not uncommonly encountered is the presence of 
extensive areas of hyalinisation (Pigs. 11 & 12).
Pig.11. Photomicrograph Pig.12. A more high-
showing areas of hyalinisation. power view is seen.
(H. & E. x 100). (H. & E. x 250).
c). Solid epithelial formation.
These are again of very diverse appearance. 
Many tumours contain a fairly solid glandular epithelium.
5X
The case illustrated in 
Pig. 13 was the only one in 
the series which bore any 
resemblance to a simple 
adenoma. In solid epith­
elial tumours of this type, 
the glandular structures 
may be arranged in tubular 
or cylindromatous fashion, 
as in Pig. 14.^
Pig. 13.
(H. & E. x 50).
fig.14.
Photomicrograph of a 
tubular or cylind­
romatous type of 
pleomorphic adenoma. 
(H. & E. x 100).
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or acinar formation (fig.15) or on occasions may be more 
papilliform (fig.lb). In the histological study of 
salivary tumours, numerous sections must be examined in 
order to get a clear view of the predominant pattern.
fig. 15. fig. 16.
Acinar formation. Papilliform type.
(H. & E. x 50). (H. & E. x 50).
d). Epithelial masses with cystic spaces.
In large epithelial masses, rounded or irre;
ular spaces may appear chiefly by the collection of
secretory products of the cells. Sometimes the
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secretory spaces assume a characteristic structure,
cribriform in type (fig.17), which resembles that seen 
in mammary tumours (Willis, 1953).
 ^-.v-
gSwGS*?.*,’iv^* ^ vt'.' t • • *___
Pig. 17. Pig. 18.
Cribriform pattern. Showing squamous metaplasia
(H. & E. x 50). (H. & E. x 70).
e). Cornifying squamous metaplasia.
Commonly in parts of these growths squamous 
metaplasia is seen (fig. 18) and is comparable with that
seen in adenocarcinoma of other glandular organs.
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f). Variations in the proportions of the epithenax 
elements and the matrix.
The proportions of the epithelial elements to 
the matrix is very variable, in some (fig. 1 9 ) a pre­
dominance of matrix with few epithelial elements is seen;
«■ m
fig. 1 9 . fig. 20.
Predominantly matrix. Mainly epithelial.
(H. & E. x 50). (H. & E. x 50).
another will be mainly epithelial (fig.20); another 
(fig. 21) where the elements are in approximately equal
proportions and yet another (fig. 22) showing a rather
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spindle-shapea growth with scanty matrix. This meshwork
10 - /v <•-;'* ■* *
vr~* ;‘§
- * • '^ t^ jaaK ■ "ar^gjFi -• ’
v- r ^ p ^ i  . 'M
Pig. 21.
In equal proportions. 
(H. & S. x 100)
Eig. 22.
Spindle-shaped growth 
(H. & E. x 100).
suspended in the mucinous matrix is the type of structure 
which was previously described as "myxo-chondroid" where
the matrix reveals its looseness with stellate cells as
seen in Pig. 2 3 .
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g)t Areas of pseudo-cartilage*
A frequent finding in many tumours is the 
presence of areas of pseudo-cartilage (Pigs.24,25, 2b)
and in rare cases even bone (Allan, 1940; fates & Paget, 
1952). The "retraction spaces" around isolated
Pig. 24.
Low-power view of 
"cartilage".
(H. & E. x £0).

epithelial cells as reported by Harve^ ex al (1938) are 
cleany seen in Pig. 2o. It is the belief of the author 
that cartilage and even bone do occur m  pleomorphic 
adenomata on occasions, although probably not as frequently 
as the pseuao-cartilage so commonly talked about.
higher-power. 
(H.& S. x 60)
Pig. 2b.
A high-power 
view in colour. 
(P.A.S. x 250).
Tiie histological study or salivary carcinomata
presents little difficulty in diagnosis as the tumours 
are invasive from the start* A typical carcinoma of 
salivary origin is shown in Fig. 27., where it arose in 
the parotid gland, and Fig. 28., arising on this occasion
in the tongue.
Fig. 27.
Salivary Carcinoma of the 
Parotid gland.
(H. & E. x 75).
Fig. 28.
Salivary Carcinoma 
arising in the tongue. 
(H. & E. x 100).
6D
The histologicax pattern of salivary adenolymph-
omata is characteristic; the epithelium having a pale 
pinh staining reaction, resembling ciosexy the ductal 
epithelium. The tumours are frequently cystic in
Fig. 29.
Adenolymphoma, ratner 
cystic in appearance. 
(H. & E. x 50).
Fig. 30.
Adenolymphoma in more 
glandular tissue.
(Ii. & E. x 50).
structure with intervening collections of small lymphocytes.
appearance (as in Fig. 29) and show branching papillary
bt

Oi one miscellaneous group ox tumours arising in
salivary tissue, only the leiomyosarcoma, ?^ hicn aro
witnin tne substance of tne parotiu gland, is shown he
Fig. 31. Photomicrograph in colour of a 
leiomyosarcoma occurring in a parotid 
gland. (Masson: s light green, x !?Oj,
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Blood groups in tumours of salivary tissue.
The idea that Blood groups may Be associated with a 
predisposition to particular hinds of disease is not new 
(RoBerts,1957), But the evidence was unconvincing until 
Aird et al (1953) deseriBed the distriBution of ABO Blood 
groups in patients with gastric cancer - group A Being more 
common than in a comparaBle control series. From such 
recent investigations into the relationship Between disease 
and the ABO Blood groups, it appears that these groups are 
associated with a susceptaBility to some disorders and 
relative immunity to others.
The incidence of group A has Been shown to Be unduly 
high in patients with pernicious anaemia (Buchanan & Higley, 
1921); Bronchopneumonia of infancy (3truthers,1951); car­
cinoma of the stomach (Aird et al,1953); diabetes melitus 
(Craig & Wang, 1955; and McConnell et al,1956) and in portal 
.cirrhosis (Billington, 1956).
Croup 0 occurs with excessive frequency in persons with
and Clarke et al (1955) pointed out that the group 0 excess 
is confined to patients with duodenal ulceration. A high 
incidence of group 0 is also noted in cases of pituitary 
adenomata (Mayr et al,1956).
Because of this increasing evidence, the blood groups
v"
of patients with tumours of salivary tissue were acertained 
during the past three years from this series. Of 395 such 
patients the blood group is now known in 341 cases.
SALIVARY TUMOURS 604
O A B A6
CONTROL SERIES 
(5,898 CASES)
The above iigure (Pig.32) shows the general results side 
by side with, those obtained in a control series of 5898 
consecutive new registrations of blood-donors at the 
regional blood transfusion centre in Glasgow in 1952-55. 
Statistically the preponderance of group A in the tumour
TA B LE #  -  SALIVARY TUMOURS -  BLOOD CROUPS
BLOOD
Cp-
Control Series Pleomorphic Ad. Carcinoma Adenolymphoma Total
No. * No. % No. % No. •4 No. n
A 1906 32.3 170 57.8 29 82.9 7 58.3 206 6 0 .4
B 637 10.8 23 7.8 1 2.8 1 8.3 25 ■ 7. a
0 3177 53.9 92 31.3 5 14.3 3 25.0 ioJT 2 0 .3
A B 178 3.0 9 3.1 - - 1 8.3 10 2 .9
All Croups 5898 100 294 100 35 100 12 99.9 341 9 9 .9
Not Grouped - - 21 - 29 - 4 - 54 -
series is highly significant. It will be seen that the 
gain in this group is at the expense of group 0. Table 
XVIII provides more detailed information about the blood
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groups oi the patients in the various types of salivary 
tumour and in the control. It will be seen that, in all 
three types, there is a striking preponderance of group A 
and a corresponding rarity of group 0 compared with the 
controls.
In analysing the figures, as groups B and AB are 
relatively constant throughout, group 0 has been compared 
with groups A, B, and AB combined together, and the results 
compared with the controls are as follows:-
a). Pleomorphic adenomata (X^ = 57.3) shows a highly 
significant percentage, with group 0 significantly 
higher for the controls as against pleomorphic 
adenoma.
b). Carcinomata (X^ = 21.9) again show a highly 
significant percentage, with group 0 significantly 
higher for the controls.
c). Adenolymphomata do not show a significantly lower
percentage of group 0 (X2 = 2.94). The indications 
however, are that, if the number of patients were 
increased, significance would be established.
■d). All types of salivary tumours were finally taken
and considered together, and, as would be expected, 
there was a highly significant (X2 = 77.9) percen­
tage, with group 0 significantly higher for the 
controls.
These findings, fully explained in Appendix I, provide 
convincing statistical evidence of an unusually high 
incidence of group A in this series of patients with 
tumours of salivary tissue. This is all the more striking 
because in Scotland group A is found in a smaller propor­
tion of the population than in England.
The selection of a control series presents a well 
recognised difficulty (Allan,1954). As a proportion 
have diseases known to be associated with certain blood 
groups, hospital patients are unsuitable. Thanks are 
due therefore to Dr. J. Wallace, Regional Blood Transfusion 
Centre, Glasgow for the data concerning the consecutive 
donor registrations.
It is the usual practice, when showing such a high
6?
incidence of a blood group and a disease, to compare tne 
blood group distribution with, carcinomata of other organs#
blood groups in carcinomata.
SITE 0 A B AB TOTAL
Salivary. 100 206 25 ' 10 341
Large Intestine. 73 54 17 2 14 6
Stomach. 109 82 27 11 229
Breast. 76 56 13 7 152
Bladder. 60 52 6 5 123
Pancreas. 15 15 3 1 34
Oesophagus. 16 8 4 2 ‘ . 30
Assistance in compiling the above table was given by 
Dr. Davies, Department of Pathology, Victoria Infirmary, 
Glasgow*
6%
Much work has "been done recently on the fate of
I
radioactive sulphur given as sulphate ion to mammals;
hut only on a very few occasons has it heen administered
to man (Borsook et al, 1957), and here the rate of
excretion is high. The results help to explain the
apparent specificity of the autoradiographic method
for mucopolysaccharides. In autoradiographs, sulphur-
35, given as the sulphate ion, is "fixed" only in the
sulphated mucopolysaccharides of the tissues, and is
present in particularly high concentration within the
cytoplasm of the cells producing them. In view of
35
the specific nature of the location of the SO ion
4
within the cytoplasm of the cells forming mucopoly­
saccharides; fibroblasts do f oim and secrete mucopoly­
saccharides into the surrounding tissues during 
collagen formation (Meyer, 1957; Curran & Kennedy,1955a). 
Bunting & Bunting; (1953) reviewed much of the evidence
for the source of the mucopolysaccharide in fibroplasia 
and came to the conclusion that an origin from 
"fibrocytes" seemed probable but not conclusive,
35
The fraction of S. sulphate r etained by various 
tissues has been shown by chemical extraction to be 
present in an esterified form, such as chondroitin 
sulphate - in skeletal cartilage and intestinal tract
H
(Dziewiatkowski, 1952, 3,4); skin (Bostrom & G-ardell, 
1953); connective tissue ground substance and collagen 
(Layton, 1951); aorta, spleen, kidney, tibia, red marrow, 
heart and skeletal muscle of chick embryos (Layton, 1952;; 
and in the healing wound in the hen (Layton, 1950,1952). 
The presence of sulphur -35 in these tissues is confl rnied 
by Curran & Kennedy (1955b) who show the invariable 
association with mucopolysaccharides, and clearly 
demonstrate that the highest activity is within the cells 
foiming mucopolysaccharide* Fibroblasts also appe ar
to show this (Curran <1 Kennedy, 1955a) and recent
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observers (C-ibson et al, 1955'; Curran 1 Gibson, 1956),
35on uptake of s in vitro by human cartilage cells, show 
activity is largely confined to cartilage cells.
It was, therefore, considered worthwhile to examine 
in vitro, human salivary tumour tissue to see whether 
the "cartilage” takes up the radioactive sulphur.
Materials and Methods.
Technique.
Immediately following the excision of a human
salivary tumour, a slice of tumour #mm in thickness was
removed under aseptic no^/-touch technique and placed in
a sterile test-tube containing 2ml of buffered Tyrode’s
35
solution. The isotope used was S, which has a half- 
life of 87.1 days and releases^ particles of energy 0.15
MeV. Into each tube was therefore^injected XOjic of
35 '
carrier free sulphate ( §) and 500 units of Crystalline
Penicillin, and the tubes incubated for 48 hours at 37°C.
Thereafter the tissue was fixed in houin1s fluid and
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and paraffin sections cut at 5-b/u. Autoradiographs were 
prepared from these by stripping-film technique, using coarse 
— and fine — grain films. Adjacent sections were stained "by 
haemalum and eosin and also "by the per-iodic acid-Schiff 
methods.
Materials.
Prom 10 consecutive human salivary tumours subjected 
to surgery, specimens were taken from each and were treated 
by the technique described above.
Results.
No. Histological Type Comment s.
1. Pleomorphic adenoma. N Y t o e
2. Pleomorphic adenoma. {\(
3. Mixed - tubular in type. Very light uptake.
4. Mixed - glandular in type Very light uptake.
5. Pleomorphic adenoma. Spoiled.
b. Carcinoma. Negative.
7. Pleomorphic adenoma. Negative.
8. Ad eno lymphoma. Negative.
9. Pleomorphic adenoma. Negative.
•o Pleomorphic adenoma. Negative.
______
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Prom the above table it will be seen that 8 failed 
uo show any uptake of sulphur— 35 at all, while 2 showed
r
only a very light uptake. In neither case was the 
material photogenic. In the first case to show any 
uptake (Case 3) the histological pattern was that of 
a tubular pleomorphic adenoma, and the uptake was over 
the epithelial cells; whilst in the other case (Case 4) 
which was of the glandular pleomorphic adenomatous 
type, the uptake was over "stromal” fibroblasts and 
over cells similar to chondrocytes.
No definite conclusions can be reached with these 
results of such a small series, and it would appear that 
rather than being a help to distinguish "pseudocartilage" 
from true cartilage, sulphur-35 used in the above 
technique is just another staining method.
7.3
PART III.
Experimental Study.
Experimental Study.
but why think, - why not try the experiment ?”
John Hunter (1775) 
Letter to Edward Jenner.
As an extension of this study of tumours of human 
salivary tissue, attempts were made to produce such 
growths in rats, mice, guinea pigs and in dogs. In 
general, these attempts have been as unsuccessful as 
have those of previous investigators. According to 
Steiner (1940, 1942, 195b) no "mixed” tumours of the 
salivary gland type have been produced experimentally in 
animals.
Since 1915, when Yamagiwa & Ichikawa succeeded in 
producing tar cancers experimentally, considerable 
progress has been made towards the elucidation of the 
chemical nature of the substances capable of inciting 
malignant changes in cells (Snear, 193b).
IS1
have been reported. lowenstein (1910) injected 
Scharlach red oil into the parotid ducts of rabbits and 
caused inflammatory changes which were claimed to resemble 
human cylindromas. Steiner (1939) described 
epidermoid cyst, squamous cell carcinoma and carcino­
sarcoma induced in rats and mice with 3.4 benzpyrene and
rt
20.methylcholanthrene. Beneche & Schroder (1939) injected 
benzpyrene in olive oil into the parotid glands of 53 rets 
and 55 mice, obtaining positive results in the form of 
sarcomas in only 2 rats. Rusch et al (1940^ surgically 
exposed the submaxillary glands of mice and introduced 
1. 2.5.6.dibenzanthracene and 3.4benzpryrene with result­
ing sarcoma and squamous cell carcinoma in a few animals. 
Franseen et al (1941) produced a^bscesses/,’ and squamous 
cell carcinoma in rats by the introduction of 
methyl^cholanthrene and 1.2.5.6.dibenzanthracene into the 
salivary glands of rats and mice. Steiner (1942)
extended his e xperiment s to the ib e of other c?reinc . ex 
and to other animals - mice, guinea pigs and rabbits, 
apart from rats. Although, tumours of the type originsll 
sought were never produced, a wide variety of cell change 
ranging from metaplasia to neoplasia were induced. lie 
types of epithelial neoplasm, were epidennoid cyst, 
squamous cell carcinoma and adenocarcinoma. The type 
of connective tissue neoplasm yere spindle cell and 
mixed cell sarcoma. Three blood vessel tumours, called 
hemangiosarcomas, were also seen. From his-observations 
on mice Steiner (1942), considered that the subs axillary 
salivary gland was more susceptable to neoplasia than 
the other salivary glands. Similar histological changes 
were seen later by Bauer 1 Byrne (1950) where the 
majority of mouse tumours produced were adeno-acanthcxza, 
Adenocarcinomas of rat submaxillary glands were produced 
by feeding with 2.acetylaminofluorine (Heiman & Ueissl, 
1946), although some years earlier Wilson et al (1941'
7?,
had failed to do so, .Viruses have also been claimed to 
produce salivary tumours experimentally in animals;
Bauer 1 Grand (1954) thought various viruses had an 
oncolytic effect on methylcholanthrene^ - ^ produced
w-
neoplsusms, while Gross (1955) following the inoculation
/
of an Ak leukaemic extract into new born C^E mice showed 
typical salivary gland carcinoma developing in the 
parotids of some of the innoculated mice. These tumours 
were microscopically adenocarcinomas becoming 
sarcomatous later.
Materials and Methods.
Following the advice of Steiner (1956) 
unnecessarily large doses of carcinogens were avoided, 
as otherwise the chemical may slough out, spread to 
expose unwanted sites and cells, produce a direct 
caustic, non-specific, injurious chemical reaction.
With this in mind, attempts were made to produce 
salivary tumours in white rats, C^H and CgK(f) strains
used were 2 0 .metliylcholanthrene and 9 .lQdim ethyl 1 .2 .
b en z an t lira c en e.
Experiment I.
In the first experiment two "batches of 24 white rats 
were used. In the first series 20,methylcholanthrene 
was injected under direct vision into the submaxillary 
gland; while in the second series an excised portion of 
submaxillary tissue containing a crystal of 2 0 .methylcho- 
lanthrene was implanted into the subcutaneous tissue on 
the back of the donor animal. All experiments were 
performed under ethe r anaesthesia and a strict aseptic 
technique was used throughout.
Experiment 2.
The animals used in this experiment were mice of 
the C3H and C3H(f) strain; no case of salivary gland 
tumour developing spontaneously in any of the non-treated
Mice vv'as noted. The technique used was a modification 
(Appendix II) of that recommended by Rous & Smith on 
numerous occasions (1945a & b, 194b, 1947, 1949, 1950), 
Using this technique 35 adult male mice were treated.
In a second series of mice portions of autogenous 
excised salivary tissue containing a crystal of 20. 
methylcholanthrene were implanted in the backs of 12 adult 
male C^H(f) mice*
Experiment 3.
The third experiment was limited to 3 guinea pigs 
and 9.10*dimethyl 1.2.benzanthracene. The carcinogen 
was implanted under direct vision into the submaxillary 
gland, again using ether anaesthesia and an aseptic 
technique.
Experiment 4*
Finally, implants of 20.methylcholanthrene were
made into both parotid glands of 10 dogs. These
80
Tlirnr operations were performed under thiopentone 
induced general anaesthesia, and each dog was given
r
1 x 10° units of Penicillin post-operatively.
/
Results.
Experiment I.
In no case was there any evidence of tumour 
formation* In six cases ohronic interstitial 
inflammatory change with intense lymphocytic 
infiltration was noted.
Experiment 2.
In 24 of the 35 adult male CgH mice, treated 
the modification of the method described by Rous 
& Smith, developed massive tumours after 10 weeks 
(Fig* 33 and 34). It was hoped that one of these,
Fig. 33. 
Photograph of the mouse 
at autopsy.
Fig. 34.
X-ray of the animal 
prior to autopsy.
at least, might prove to be of salivary origin but
histologically they all appeared to have the general
characteristics of a highly cellular anaplastic spindle 
cell sarcoma, probably a variety of "myosarcoma" (Fig.35)
8%-
Fig. 35.
Photomicrograph of a 
"myo-sarcoma" produced.
( H. & E. x 80 ).
The tissue transplanted, together with the carcinogen, 
into the back of the donor animal survived in only 5 
cases, and in 2 of these the salivary epithelium had 
disappeared, or had suffered a squamoid type of chd'&e.
i\
It was scattered in a disorganised way in a cellular 
stroma. There was in addition much inflammatory and 
foreign body reaction; some of the injected foreign 
material could still be seen in fat-laden phagocytes. 
The epithelial picture (Fig. 3b) in certain respects
• r 4 , j
te'™' ''i < *
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resembled that of a squamous epithelioma and was not 
unlike a picture occasionally found in parts, of human 
pleomorphic salivary adenoma or carcinoma. It would 
obviously, nowever, he stretching evidence unreasonably 
to regard this as histological evidence of artificial 
production of a mixed salivary gland tumour.
Pig. 3b.
Photomicrograph of the 
epithelial picture 
described above.
( H. & S. x 100 ).
Pxperiment 3.
After 3 months there was a palpable and visible 
enlargement of the submaxillary glands in the 3 guinea 
pigs, but histological examination only showed chronic
inflavatory change with abscess f ormation. There was
i
K.
no evidence of tumour formation.
Experiment 4*
At autopsy 6 to 60 weeks later 7 of the 10 showed 
visible and palpable enlargement of the gland. 
Histologically, however, there was only a vigorous 
inflammatory reaction, marked fibrous and in places 
squamoid change in the epithelium. In other parts there 
was some proliferation of the acinar epithelium. These'
Fig. 37.
Photomicrograph of 
tissue from dog 
parotid showing 
changes described 
in text. ( H. A E. 
x 100 ).
changes show some similarity to those referred to earlier 
in the mouse implants, but in none was a true tumour of 
salivary tissue produced.
8f
therefore, attempts to reproduce experimentally 
in animals anything resembling a salivary tumour, let 
alone a "mixed salivary tumour" have failed.
$6
TAET IY
Conclusions and Summary.
CONCLUSIONS
A clinico-pathological and experimental study of 
tumours of salivary tissue has been made. A series of 
401 clinical cases have been investigated and the results 
reported. From this survey it would appear that it is 
only necessary to classify such tumours as:-
a). Pleomorphic adenoma,
b). Carcinoma, and
c). Ad eno lymphoma.
The type previously classified as Simple Adenoma'is only 
a variety of pleomorphic adenoma, and so does not need a 
separate classification. Also the miscellaneous group 
of tumours hardly enter the survey as they are only 
rarities and can occur in almost any organ. Working on 
this basis the survey will be discussed.
a). PIeomorphic adenoma.
Of the 80$ of pleomorphic adenomata occurring in the
parotid gland there was a slight preference for the right
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side; it was also observed that bOg occurred before
the age of 40 years and SOg before the age of 50 years*
It is agxeed that such tumours show a slow intermittent 
growth and that they can reach gigantic size .(Case ho. 221). 
The recurrence rate of almost 30$ is due to the following 
reasons:-
i. general habit of such tumours,
ii. subjected to operation before being fully 
investigated, and before all the nodules 
of tumour tissue have joined together, 
that is in keeping with the multicentric 
origin theory*
iii. surgery not radical enough; all such 
tumours should be looked upon as 
potentially malignant and radical excision 
undertaken.
In this series there was noted on 3 occasions a familial
incidence, a fact which had apparently not been reported
on before in the literature. In the first family there
is histological proof; in the second, clinical observations
must be relied upon; and in the third family the evidence
is so circumstantial as to be almost certainly valid.
As previous workers irve already described, there is
correlation between the histological pattern and the
clinical course of the tumour, tut, one cannot sgreewit
McFarland (1926) when he stated that, "nothing of 
prognostic value results from the microscopic study of 
a mixed tumour". In cases which recurred the 
histological picture was more often than not similar 
to the original material, but in some cases it was more 
cellular. There was, hov^ ever, no tendency towards a
malignant tumour is mainly malignant from the onset and 
does not develop from a pleomorphic adenoma.
Histologically there are many variations of
variations of structure may be found in close
\
juxtaposition with all graduations between them; while 
in others, one or another structural variant predomin­
ates. Much has been written on the presence of areas 
of "pseudo-cartilage", and many deny the possibility of
more i malignant pattern. In other words, a
pleomorphic adenomata
9©
such a finding. In spite of having been unable to urove 
or disprove this theory by in vitro tests with radioactive
 ^£T
sulphur (S ) 011 slices of human salivary tumour, there 
would appear to be no reason why cartilage, or even bone 
on rare occasions, should not be seen on histological 
section. Whether the cartilage is present from the 
onset of the tumour, or that it arises by metaplastic 
change will be,for some time to come^a matter for 
research.
b). Carcinoma.
Carcinomata of salivary tissue is usually heralded 
by a tumour showing a rapid increase in size with 
associated pain and/or paralysis in a patient in a 
slightly older age group. The sex incidence as with side, 
is not convincing statistically. As would be expected 
the recurrence rate is high, and the death rate equally 
raised. As the tumours are invasive from the start, the
histological study presents little difficulty in diagnosis
U. OllUi- J.y .
c). Ad en o lymphoma.
Only 4/'° of the tumours in this series were 
classified as such, and all "but one occurred in the 
parotid glands. The outsider arose in the tonsil.
On four occasions the adenolymphomata were bilateral, 
and the sex ratio was equal in this series. Such 
tumours have a characteristic histological pattern.
Blood-groups in salivary tumours.
A statistical preponderance of group-A in the 
tumour series over the control is clearly demonstrated 
< and that the gain is at the expense of group-0. It is 
shown that in all 3 types of salivary tumours the 
preponderance of group-A and a corresponding rarity of 
group-6  compared with the control series is striking. 
Although in the case of Adenolymphomata significance is 
not established, the indications are^ that if the numbers
f
were increased/ significance would oe established.
/ 9%
It is hoped that it will be possible to determine 
the secretor status of some of the sample in the future, 
in order to determine whether secretion of group specific 
substances comes into it (Fraser Roberts, 1958).
Experimental study.
Attempts were made to produce salivary tumours in 
animals experimentally, using carcinogens. But like 
previous workers, tumours resembling the human mixed 
salivary tumour did not result. In rats and guinea-pigs 
only acute and chronic inflammatory changes were produced, 
while in mice numerous tumours were produced in the hind­
leg following the technique described in Appendix II.
All of these tumours showed a highly cellular anaplastic 
spindle cell sarcoma, In the same strain of mice and in 
some dogs there was a vigorous inflammatory reaction with 
much fibrosis and some squamoid change in the epithelium 
and also some proliferation of the acinar epithelium.
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(This, however, cannot he regarded as histological 
evidence of artificial production of a mixed 
salivary tumour#
94-
SUMMARY.
i. A clinical study has been made of 401 cases of 
tumours of salivary tissue and the results reported^ 
familial incidence being noted on 3 occasions,
ii. A histological study has beoa made of those cases 
seen at the Southern General Hospital, Glasgow* Attempts 
were made to clarify the presence or absence of "cartilage” 
in pleomorphic adenomata using Sulphur-35 with no result,
iii. Blood-grouping was cariied out in 341 patients from 
this series, and a highly significant preponderance of 
group-A was noted as compared with the control series.
This preponderance was also present in the separate types 
of salivary tumours as well as in salivary tumours in 
general.
iv. The results of attempts to produce salivary tumours 
experimentally in animals is discussed.
v. The literature is reviewed in all parts of the thesis.
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APPENDIX I.
Statistical analysis of blood groups in Salivary Tumours.
All the various types of salivary tumours were 
compared with the controls. The only one which does 
not. show a significantly lower percentage of group 0 is 
in Adenolymphomata where only 12 patients are considered. 
The indications are, however",: that if the numher of 
patients is increased then significance will be 
established. All types were also tested taken together, 
although in view of the significance established for two 
of the varieties of salivary tumours, I do not think 
that this test was necessary, 
a). Pleomorphic Adenomata.
Blood- Control. Pleomorphic Total,
group. Adenomata.
o 3177 92 3269
Non-0 2721 202 2923
Total 5898 294 6192
2. (3177 x 202 - 2721 x 92)2 6192
X a 5o98 x 294 x 3269 x 2923
.
153,211,182,084 x 1.049847
57-3 135.
significantly higher for the controls as against 
pleomorphic adenomata.
h). Salivary carcinomata.
Blood- 
group.
Control. Carcinoma. Total
0 3177 5 3182
Non-0 2721 30 2751
Total 5898 35 5933
», (3177 x 30 - 2721 x 5 )2 5933
2 = 5'898' x 35 T1 T S ? ~ 2 7 5 I---
6,675.707,025 x 1.0059342
=  ' Wb, s w , m
21.7891 x 1.0059342 
21.9
This is again a highly significant percentage with group 0 
significantly higher for the controls.
0). Adenolymphomata.
Blood- Control.. Adenolymphomata. Total,
group
0 3177 3 3130
Non-0 2721 9 2730
Total 5898 12 
136.
5910
305,375,525 x 1.0020346 
TOT, 175,800
2.93132 x 1.00203
2.94
As has been stated this is NOT significant, 
d). All types together.
Blood- 
group.
Control All types. Total.
0 3177 100 3277
Non-0 2721 241 2962
Total 5893 341 5239
^3498,512.> 249 x 1.0578162
77.9
As would he expected this percentage is highly 
significant.
All these figures have heen checked hy Dr. E.A. Rohh, 
Mathematics Department, Glasgow University and to v/hom 
I am indebted.
. ~i-' J.' Juii jjl ux. XI •
Technique used in Experiment 2.
The technique used was a modification of that
described "by Hous & Smith on nimerous occasions (1945a a b,
1946, 1947, 1949, 1950).
i. Rewly horn mice were killed with coal gas and 
washed in Locke’s solution.
ii. Using the dissecting microscope the salivary tissue 
was removed as aseptically as possible.
iii. . With locks's solution a suspension of salivary tissue 
was made.
iv. A 0.25ml. Luer syringe was taken and 0.05ml. of the 
suspension of salivary tissue drawn up; followed 
by 0.05ml. of a 1 fo suspension of 20.methylocholan- 
threne in olive oil.
v. After cleaning the right thigh of the adult male 
C3H mouse, a lb gauge needle was fitted to the 
syringe and the contents injected into the thigh.
vi. The thigh was not palpated for 2 weeks.
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APPENDIX' III,
Clinical Material, 
i. Pleomorphic adenoma.
No* Sex.
Age at 
onset.
Age at 
1st. op. Rec. Hist. No. Sit. Side. Hosp.
Blood 
group.
1. M. 37 40 - 1578/49 P I G.R.I. 0.
2. P. 49 52 - A5 3 79/5 5 P L G.R.I. B.
3. P. 39 42 + C3009/56 P L G.R.I. Ji.. +
4. M. 39 51 + /45 P R G.R.I. 0. +
5. P. 28 48 - G 5/49 P L G.R.I. A.
6. M. 32 57 +■ 1086/39 P R G.R.I. 0. -
7. M. 29 32 — 1313/56 P L G.R.I. A.
8. M. 68 70 +• Law / P R G. R. I. Jie +
9. M. 44 45 — 869/45 P R G.R.I. A.
10. P. 46 49 - 219/53 P L G. R* I • A.
11. M. 39 59 - /57 Sx L G.R.I. 0. +
12. M. 49 52 _ C1299/42 P R G.R.I. A. +
Age at Age at
No. Sex. onset. 1st. op. Rec. Hist. No. Site. Side. Eosp.
H o o d
13. M
14.
15. P
16.
17. P
18. P
19. F
20.
21. P
22. M
23. P
24. P
25. P
26. M
27. P
28. i*
34
37
58
56
59
30
31
43
13
68
19
60
51
2U
36
48
65
62
59
35
35
43
14
15
69
20
65
52
42
21
+ 1186/43 P R G.R.I, T3
1441/43 P
1890/42 P
- P0733/56 P
2671/53 lip
51 P
814/41 P
1376/56 P
860/43 Cheek
I t o M 45 P
R
G.R.I. -
G.R.I. 0,
G.R.I. B,
+ 4109/53 P R G.R.I.
+ 1419/44 P R G.R.I. A.
C /56 Pal - G.R.I. 0. +
R G. R. I. A. -}-
+ 1840/44 P R G.R.I. 0. +
St /54 P L G.R.I. A. +
R G.R.I. 0
L G.R.I. 0.
■* R • 1. 0
G.R.I. 0
R ; G.R.I. 0
Age st Age st .blood
No. Sex. onset 1st. op. Rec. Hist.No. Site. Side. Kosp. group.
29. - M
30. F
31. P
32.
33.
34.
35.
36. P
37.
38. P 
39* F
40. P
41. P
42. P
43.
44. M
58
24
42
46 
36 
68
17 
53 
35 
44 
41 
26 
35
18
47 
39
68
28
62
49 
36 
77 
29 
57 
43 
48 
45 
28
50 
19 
52 
43
1333/39 P E
4715/54 P 1
+ St395l/51 P E
3247/56 P L
1339/50 P L
O'ban
4992/54 P E
431/50 P E
+ 2272/54 P E
C5 470/5 5 Sx E
+ 4374/54 P I>
2000/42 P 1
+ 1429/43 Sx L
2262/48 P h
G.R.I. — 
G.R.I. A. 
G. R.1. 0.
G.R.I. B.
311/52 P R G.R.I. 0.
58/44 P E
G.R.I. A. •+• 
G. R. I • A. + 
G.R.I. Au. 
G.R.I. 0. 
G.R.I. 0. + 
G.R.I. 0. 
G.R.I. 0.
G. R. I. A. 
G.R.I. A. 
G.R.I. A. 
G.R.I. A 4-
141.
Age at Age at Blood
No. Sex. onset. 1st. op. Eec. Hist.No. Site. Side. Fosp. group.
45. M. 37 42 -  1199/45 P E G.R.I. A3.
46. M. 56 57 -  1220/38 P L G.R.I.
47. P. 55 56 + 1764/42 P L G.R.I. B.
48. P. 16 18 -  L2767/50 P R G.R.I. A. +
49. M. 57 59 -  170/39 P R G.R.I. A. +
50. P. 30 38 -  2879/51 P L G.R.I. 0.
51. M. 14 15 + 2017/38 P L G.R.I. A.
52. P. 29 36 -  744/44 P E G.R.I. A.
53. P. 67 75 -  2744/48 P L G.R.I. A.
54. M. 22 23 -  1776/46 Lip -  G.R.I. A. +
55. M. 35 36 + 2010/47 P R G.R.I. A. +
56. P. 65 77 + 4090/50 P R G.R.I. 0.
57. P. 49 53 -  1893/43 P R G.R.I. A. +
58. M. 30 50 -  2517/48 Sx R G.R.I. 0. +
5 9 . p. 49 52  -  1790/37 P R G.R.I.
60. M. 30 45 V2044/53 Pal. — u.R.I. 0. —
1 4 2 .
. .'lood
No. Sex. onset. 1st. op. Rec. Eist.No. Site. Side. Eosp. group.
Age at Age at
61. F
62. F
63.
64. f
65.
66.
67. F
68. F
69. M
70. F
71. F
72. F
73. M
74. M
75. F
76. F
26
51
37
44
52
46
29
36
52
18
33
36
44
43
23
29
52
38
45
62
49
30
37
52
26
34
46
46
57
26
V 81/53 Pal
982/55 P
752/38 P
+ 1251/53 Lip
82/46 P
G* R. X. A. +
R G.R.I. 0
L G.R.I. A.
L G.R.I. A.
G.R.I. AB.
L G.R.I. A.
+• St /45 P I G.R.I. A. +
C1756/55 lip G.R.I. A.
+ G /47 P H G.R.I. A.
+ 280/49 P
i- Bristol/43 P
1128/56 P
+ 4101/56 P
2868/55 P
3878/50 P
2044/55 P
1 G.R.I. A. +
• R. I • A.
R G.R.I. 0. +
L G.R.I. A.
R U-• R. I. B.
L G.R. I. A.
R G.R.I. 0,
143.
Age at Age at _ Jlooa
No. Sex. onset. 1st. op. Rec. Hist.No. Site. Side. Hosp. grou]
77. P. 29 42
78. F
79- F
81. F
83. F
85. M
86. F
87. F
88. F
89. M
90. M
91. F
92. F
38 40
18 19
73 74
38 39
39 43
26 35
37 40
47 48
42 57
22 30
13
28 30
37 38
39 40
25 28
+
410/55 P
L G .R .I .  G.
R G .R .I .  0.
R G .R .I .  0 .
X* G .R .I .  A .  -f-
+ 1757/52 Pharynx G .R .I.
1659/53 P 
702/39 P 
— E P
539/51 P 
561/39 P 
+ 1902/51 P
1265/53 P 
1055/47 P 
2267/49 P 
398/56 P 
790/52 P
R G. R. I  • C •
R G .R .I .  B.
R R . I .
Xi G .R .I .  A.
L G .R .I.  A.
L G .R .I .  0.
R G .R .I .  A.
L G .R .I .  AB. 
R G .R .I.  A .
L G .R .I.  0.
jj G. R . I  • A*
144.
Age at Age at Blood
No. Sex. onset. 1st. op. Rec. Hist.No. Site. Side. Eosp. group.
93* P. 24 29 +■ St4377/53 P
94. P. 66 67 — 2434/48 P
95. P. 62 64 - 5603/54 P
96. P. 20 24 +■ /49 P
97. ffi. 12 15 — 1872/43 Lip
98. M. 38 43 ■ - 1550/45 P
99. P. 50 56 — 2941/56 P
100. P. 12 18 — C 91/49 P
101. M. 34 40 875/36 P
102. M. 33 35 +■ P
103. P. 37 39 - 3040/50 P
104. P. 29 31 - 435/51 P
105. P. 51 54 — 2950/55 P
106. P. 33 35 - - P
107. M. 28 29 - Law P
108. M. 19 23 + 273/36 P
145.
R G.R.I. A.
L G .R .I.  A. -
R G .R .I.  A. +
H n -p T r'-o r. i t .  -L .  x l .
—• G. R. I . A. —
R G .R .I.  A. +
R G .R .I.  0.
R G .R .I .  -
R G .R .I .  0 .
L G .R .I .  0 .
R G.R. I  • A.
R G .R .I .  A.
R G .R .I .  A +
L G .R .I .  A. +
R G .R .I .  A. +
L G.R*I. 0. +
Age at Age at Blood
No. Bex. onset. 1 st. op. Rec. Fist.No. Site. Side. T'osp. group.
109. P. 23 27 + 1930/39 P L G.E.I. A.
110. P. 58 73 - - P I G.E. I. A.
111. P. 38 42 - 79/55 Sx L G.E.I. 0 . +
112. M. 24 27 - 507/55 P L G.R.I. A. +
113. P. 23 26 - E3 202/50 P L G.R.I. A.
114. M. 26 28 + 1922/ P R G.R.I. A.
115. P. 46 52 + - P L G.R.I. A.
116. P. 48 49 +- Ayr P R G.R.I. B. +
117. P. 26 30 - P19 63/53 P R G.R.I. 0 .
118. P. 30 31 + 1936 P L G.R.I. 0.
119. P. 49 - 5 4  - 1219/38 P L G.R.I, 0.
120. M. 36 41 + 0  /52 P R G.R.I. A. -
121. P. 31 51 + 1929 Pal. - G.R.I. A. -
122* P. 43 46 + 1934 Sx R G.R.I. -
123. P. 37 38 - 699/49 P R G.R.I. 3.
124. M. 28 30 - Y15 22/51 Pal. “ G.R.I. a .
146.
AAge at Age at Blood
No. Sex. onset. 1st. op. Rec. Hist.No. Site. Side. Hosp. group.
125. P.
126. M,
127. P
128. P
129. P
130.
131. P
132. P
133. P
134.
135.
136.
137. P
138. M
139.
140.
141. P
39
67
45
27 
23
28 
71 
27 
39 
22 
42 
70 
61 
36 
59
13
55
42 
68 
48 
47 
33
29 
72
30 
40 
40
43 
80 
63 
40 
70
40
75
168/46 Pharynx. G-.R. I. A.
613/44 P 
676/43 P 
1137/42 P
- 1017/39 P
- 3653/51 P
- 1883/53 P
- a /53 p
- 71348/45 Sx 
+ 1940 p
2526/52 lip
- St3986/55 P
- 402/43 lip
+ 2257/47 P
- 1853/45 P
221/48 P
- X /51 P
E G.R.I
E
R
1
R
1
1
R
R
R
G. R. I. —
G.R.I. B. 
G.R.I. 0. 
G.R.I. A.
G. R. I • A. + 
G.R.I. A. - 
G.R.I. 0 . 
G.R.I. A. + 
G.R.I. A. 
G.R.I. A. 
G.R.I. 0. 
G.R.I. 0. 
G.R.I. A.
R G.R.I. 0.
R G.R.I. A. a
Age at Age at Blood
No. Sex. bnset. 1st. op. Rec. Hist.No. Site. Side. Bosp. group.
14-2. M,
143. P.
144. M,
145. M
146. F
147. P
148. P
149. P
150. M
151. P
152. P
153. P
154. 1
155. M
156. P
157. M
<34. 38 - 1428/43 P I* G.R.I. A.
52 54 - 0‘ban/5 6 P R G.R.I. 0. +
44 48 - Hel /42 P R G.R.I. A.
9 12 + 2047/52 P R G.R.I. A. +
41 45 - 1299/45 P L G.R.I. 3.
20 22 - Y2840/52 Pal. - G.R.I. AB.
53 54 - Y143 5/51 Pal. - G.R.I. A.
. 15 27 - A4240/53 Tonsil - G.R.I. 0 .
44 45 - 317/45 P L G.R.I. A.
71 74 - Ayr /55 P R G.R.I. A. +
23 26 * 2657/52 P R G.R.I. 0.
5 4 | 9  - 892/38 P.: R G.R.I. -
37 67 +■ 593/52 P , R G.R.I. 0 .
18 21 + 222/44 P L G.R.I. A.
40 50 + 1952 Pal - G.R.I. A. -
79 80 1268/41 P B u-.R.I. —
■ 148.
Age at Age at Blood
No. Sex. onset. 1st. op. Rec. Hist. No. Site. Side. Eosp. group.
158. M. 14 17 - 1750/38 P R G.R.I. A.
159. F. 34- 3b - 951/39 P R G.H.I.
160. M. 48 49 - 499/50 P L G.R.I. A.
161. M. 52 53 - 1935/55 Sx L G.R.I. A5. -
162. M. 24 25 - 1484/47 Pal. - G.R.I. 3.
163. M. 30 35 - 1182/47 P L G.R.I. 0.
164. F. 58 59 — 1085/47 P 1 G.R.I. n. +
165. Iff. 57 58 - ~ P R G.R.I. A.
166. M. 50 59 - 259/50 P L G.R.I. A. +
167. M. 18 19 ~ 1.653/38 Pal. - G.R.I.
168. F. 59 68 - 663/44 P 1 G.R.I.
169. M. 37 40 + /40 P L G.R.I. A.
170. M. 37 47 - 1212/38 P L G.R.I.
171. F. 19 21 - 514/45 P R G.R.I. 0.
172. M. 18 19 + 1855/45 P I* G.R.I. 0.
173. F. 33 38 — 1145/47 P R G.R.I. 0 .
174. F. 19 22 G /55 p 1 G.R.I. A. +
149.
No. Sex.
175. P.
176. P.
177. P.
178. P.
179. P.
180. M.
181. M.
182. M.
183. P.
184. M.
185. P.
186. P. 
18% . P
188. M
189. P
190. P.
191. P
A^e e.t Age '/-j -■Lwl'u
onset. 1st. op. Eec. Hist. Mo. Site. Side. IIosp. grcuo
3b 42 - Lewis/55 P H G.E.I. A.
3 5 50 + 27 61/49 P B G.E.I. A. +
52 55 + 128b/ 42 P L G.R.I. A. +
29 31 + /44 P E G.E.I. 0.
50 54 - 3488/53 Lip - G.E. I. A.
69 70 + A /35 Sx R G.E.I.
77 78 - A4909/52 Lip - G.E. I. A. -
70 75 - /55 Pal. - G.E.I. A. +
32 34 - 3137/52 P E G.E.I. A.
59 63 - llbO/45 P L. G.E. I. A. +
59 59 + EP1878/53 Cheek - G.E.I. 0.
35 37 - 1737/43 P E G.E. I. A.
56 63 - 5725/54 P E G.E. I. A. +
17 18 - Stl7&0/55 P E G.E.I. 0. -
52 53 - 4089/55 P E G.E. I. A»-.
2i 37 + 1890/51 P -k G.E. I. 0. +
53 54 — C449/50 p R
15--
li
Age at Age at Blood
No. See. onset. 1st. op. See. Hist.No. Site. Side. Eosp. group.
192. M.
193. M,
194. P.
195. P 
19b. P. 
1971 P.
198. M.
199. F.
200. P.
201. P.
202. F
203. P
204. P
205. P
206. M
207. P
208. P
33 43 - St /47 P L G.E.I. A. +
3 2 3 3 - 2415/48 P I G.R.I. 0.
29 37 - 3037/52 P X> G.E. I. A. +
50 55 - 822/48 P , R G.R.I. B.
35 41 + /32 P E G.E.X. 0. -
64 65 - 5238/53 P 1 G.R.I. A. +
37 38 + 1583/51 Chin - G.R.I. 0.
51 52 - 872/46 P R G.R.I. A.
35 40 - 1094/40 P R G.R.I. AB.
34 36 - 2255/48 Sis 1 G.R.I.- A. -
68 74 . - 2057/55 P I G.R.I. 0.
65 66 ~ 27/55 P B G.R.I. A. +
45 75 - L25 21/50 P R G.R.I. -
44 54 - 1659/42 P L G.R.I. 0. +
14 15 + 365/53 P 1 G.R.I. 0.
20 22 + Bal P S G.R.I. 0.
69 - S3062/56 P R G . E .I. a. -h
Age at Age at Blood
No. Sex. onset. 1st. on.'Rec. Hist.No. Site. side. Kosp. group.
209. P. 12 42 - 4957/53 P 1 G.R.I. 0.
210. M. 12 14 + 0 79/49 P R G.R.I. A.
211. M. 46 58 - - P R G.R.I. A.
212. P. 25 30 - V3155/50 Pal. - G.R.I. A.
213. M. _ 21 22 - 2127/50 P R G.R.I. 0.
214. P. 21 22 * 1187/43 P 1 G.R.I. 0.
215. P. 28 30 - 1533/37 P R G.R.I. 3.
216. P. 42 43 - 2054/48 P L G.R.I. 0.
217. P. 23 27 + 252/48 P I G.R.I. 0.
218. P. 48 58 149/46 P L G.R.I. A.
219. P. 44 45 - 4809/55 P 1 G.R.I. A. +
220. P. 39 45 - 1744/46 P R G.R.I. A. +
221. P. 34 35 + /38 P. R G.R.I. 0 . +
222. M. 63 r 65 + 2443/49 Sx L G.R.I. A.
223. P. 63 70 - - P R G.R.I. A. -
224. P. 32 52 - P 373/56 P L G.R.I. A.
2?5. ■«. 33 41 - 1015/45 P L G.R.I. A.
152.
nlood
No. Sex.onset. 1st. op. Rec. Hist.No. Site. Side. Hosp. broup,
226. P. 47 52 - 1277/45 P R G.R.I. A. +
227. P. 23 25 - 682/47 P L G.R.I. 0 . -
228. P. 16 18 - Eng/ P L E!ng. 0 . -
229. P. 6$ 65 - St /50 P L G .R .I.  A. +
230. P. 22 23 + 350/49 P L G.R.I. A. +
231. M. 25 35 - 369/48 P E G.R.I. A3.
232. P. 39 42 - 2825/53 P R G.R.I. A.
233. P. 16 19 + 2179/47 P L G.R.I. 3.
234. M. 90 91 + - P I  G.R.I. - .
235. P. 39 40 - 2190/46 P 1 G.R.I. 0 .
236. M. 70 72. - 1162/46 P I G.R.I. A. +
237. M. 76 77 - ? 1 G.R.I. A. +
238. M. 48 56 - Bal. P R G.R.I. 0 . +
239. P. 21 22 + 1307/41 P R G.R.I. A.
240. M. 46 48 — 0 /4 6 P R u-.R.I. — •
241. M. 43. 46 - 130/53 Sx R G.R.I.
153.
Age at Age at 131 ood
No. Sex. onset. 1st. op. Rec. Hist. No. Site. Side. P'osp. :^rcup,
242. F. 49 58 - C 97/49 P R G.E. I. A.
243. P. 25 40 - 1472/53 P R S.G.K. 0 .
244. P. 40 41 - P553659 P E W.I.G. 0 .
245. F. 70 76 - - P I S.G.H. 0.
246. . M. 51 61 - 882/50 P E S.G.H. 0.
247. F. 49 59 - 21579/54 P 1 W.I.G. A.
248. F. 43 45 - HE523551 P E W.I.G. -.
249. F. 37 52 - 1308/52 P E S.G.H. A.
250. F. 47 48 + 1789/52 P E S.G.H. A.
251. F. 4b 59 + / 41 P L W.I.G. A.
252. F. 39 57 + 881/41 P 1 W.I.G. A.
253. F. 33 335 - 429/55 P E S.G.H. A. -
254. F. 49 52 - 1750/50 P E S.G.H. B.
255. F. 52 55 - W.I.G./54 P R W.I.G. A.
256. M. 32 33 - HR500704 P 1 W.I.G. B.
257. F. 43 44 - 59 C/52 P R 3.".”. A.
258. 59 do + - p h  g .a .i . o.
e. •* ’ 0 . A 0 • t *.10 0 d
Ho. Sex. onset. 1st. op. Rec. Hist.Ho. Site. Side. Hosp. proup.
259. M. 20 25 + HR480796 P L W.I.G. C.
260. P. 28 51 + ER501274 P 1 W.I.G..
261. P. 26 41 - HR522525 P R W.I.G. A.
262. F. 54 56 - HR540971 Pal. - W.I.G. A.
263. M. 30 37 - HR5.11384 P R W.I.G. 0 .
264. P. 42 43 - HR523594 P L W.I.G. A.
265. M. 39 40 - HR533457 P L W.I.G. A.
266. F. 35 37 - EE543876 Tonsil W.I.G. 0.
267. F. 39 49 - HR501526 Sx R W.I.G. A.
268. M. 34 39 - P554609 P R W.I.G. 0 .
269. M. 50 51 + 1571/53 Sx L S.G.H. A.
270. M. 19 21 - 549/53 P I S.G.H. A.
271. B. 19 21 - /55 P R S.G.H. A.
272. M. 37 45 + 62/50 P L S.G.H.
273. F. 20 23 - 1166/50 P L S.G.H.
274. F. 30 42 - HR531252 P R '7.1.7. A.
275. F. 26 56 - HR530621 P R 7.I.G.
155.
Age at Age at Blood
Ho. Sex. onset. 1st. op. Rec. Hist.No. Site. Side, ilosp. group,
276. M. 24 39 + HR501436 P I W.I.G. B.
277. M. 40 50 - 1611/52 P L S.G.H. 3.
278. F. 40 45 - 1875/53 P R S.G.H. 0.
279. F. 42 . 43 - HR5 22409 P 1 W.I.G. A.
280. M. 26 31 + 2224/54 Sx I S.G.H. A.
281. F. 84 85 - HR542203 P R W.I.G. 0 .
282. IS. 42 48 - HB510782 P L W.I.G. 0.
283. F. 30 32 + /50 P L W.I.G. A.
284. F. 18. 22 - /56 Sx R S.G.H. 3 .
285. F. 39 54 - 675/55 P R 3.G.E. 0 .
286. M. 48 53 - 32/54 Pa. - S.G.H. 0.
287. M. 20 22 - 1559/55 P R S.G.H. A. +
288. M. 54 62 * HR5 23880 P L W.I.G. A.
289. F. 43 53 - HR501638 P R W.I.G. A. +
290. F. 20 21 - /55 P R W.I.G. 0.
291. F. 23 31 - 504/51 P L S.G.H.
292. F 43 55 “ 1218/51 P
1 5 6 .
Age at Age at Bloocl
No. Sex. onset. 1st. op. Rec. Hist.No. Site. Side. Hosp. group.
293. F. 22 42 - HR543976 Sx I W.I.G. 0.
294. F. 54 59 - HR500573 P L W.I.G. G.
295. F. 46 52 - 565/56 P R S.G.H. 0.
296. M. 29 40 - /53 P R W.I.G. A.
297. F. 440 43 - Falkirk/54P R Falkirk A.
298. F. 33 59 - HR550398 P R W.I.G. A.
299. F. 58 62 + HR543913 Sx R W.I.G. A.
300. M. 59 60 - 1368/55 Sx I S.G.H. A.
301. F. 13 21 + 1889/54 P R S.G.H. A.
302. F. 38 39 + P554396 P R W.I.G. A.
303. M. 71 72 - 1384/52 P I S.G.H. B.
304. F. 34 54 - /54 P R W.I.G. A.
305. F. 48 56 - 242/52 P R S.G.H. A.
306. M. 45 50 + /49 P 1 W.I.G. 0 .
307. F. 39 44 - P551280 P L W.I.G. A.
308. M. 52 53 + HB482426 SI. L W.I.G.
309. H. 18 30 32148/5o P R G.R.I. A.
157.
*No. Sex.
Age at Age at 
onset. 1st. op. Rec. Hist.No. Site. Side. Hosp.
Blood 
group.
H o • • 28 35 + 680/50 P R Gr.R. I. A.
311. P. 47 48 814/39 P R G.R.I. A.
312. F. 32 34 - 2106/47 P R. G.R.I. A.
313. F. 58 60 - 233/47 P L G. R. I • A.-
314. M. 26 27 - 1034/53 P R G.R.I. A.
315. F. 38 40 1610/47 P L G.R.I. A.
ii. Carcinoma.
No. Sex.
Age at Age at 
onset. 1st. op. Rec. Hist.Bo. Site. Side. Hosp.
Blood 
group.
316. M. 21 39 - f 2342/56 P L G.R.I. A.-
317. M. 64 64 + HR533512 Pal. — W.I.G. A.+
•*COHrO 60 62 HR503560 SI. L W.I.G. 0 .
319. M. 16 26 + K496/54 P R G.R.I. A.~
320. P. 72 73 + Law. P L G.R.I. A.
321. F. 44 74 +
158
G550336
m
P R W.I.G. A *
No, Sex,
Age at 
onset.
Age at 
1st. op. Rec. Hist.No. Site. Side.
Blood 
Hosp. group.
322. P. 65 66 — 01536/44 P L Gr. R* I • A .+
323. M. 60 60 + K421 P R G.R.I. 0.
324. M. 20 32 + V1935/53 Pal. — G.R.I. A.
325. P. 57 57 /54 Tongue S.G.H. A.
326. P. 60 60 + Stranraer P L G.R.I. A.
327. M. 47 57 + HR482135 Sx L W.I.G. A.
328. M. 75 78 + Law/54 P R G.R.I. A.+
329. P. 66 68 + 987/36 P L G.R.I. -
330. M. 20 60 - 1789/37 P L G.R.I. -
331. M. 48 48 + 4072/54 P L G.R.I. A
332. F. 72 72 + 1913/48 P L G. R. I. A.
333. P. 63 63 - 1105/41 P R G.R.I. -
334. M. 60 62 + 742/38 Sx L G.R.I. -
335. M. 28 48 + P551572 P L W.I.G. A. +
336. 1. 43 66 + 1455/35 P R G.R.I. -
337. P. 29 73 + V2517/50 Lip - G.R.I. _
338. M. 71 71 + 1452/41
159.
Pal. - G.R.I. -
No. Sex. onset. 1st. op. Kec. Hist.No. Site. Side. Hosp. group
339. F. 62 62 + 3236/51 P R G.R.I. A.
340. M. 53 53 - 610/39 Sx R G.R.I. -
341. F. 48 49 7227/52 Pal. - G.R.I. -
342. M. 79 79 + 1165 /50 P R. G.R.I. —
343. M. 55 55 4' E/50 Pal. - G.R.I. A.
344. M. 52 52 4* HR532050 P L W,I.G. —
345. M. 64 64 + 1036/48 P 1 G.R.I. -
346. M. 48 63 Edin/4 8 P L G.R.I. 0.
347. F. 10 11 + HH493167 P L W.I.G. A.
348. F. 20 20 + 13 61/38 P 1 G.R.I. A, +
349. F. 51 52 4- . 1850/35 P L G.R.I. -
350. M. 1 0 1 1 — 1368/43 P R G.R.I. 0 .
351. M. 73 74 4* 1320/38 P R G.R.I. -
352. F. 6 1 6 6 + HH523149 P R W.I.G. —
353. M. 55 59 4* 1564/40 Nose G.R.I. -
354. F. 74 78 4* HR542544 P R Y/. I. G, A.
355. M. 53 53 4* 1352/48 Sx R G.R.I•
160.
Age at Age at Alood
No. Sex. onset. 1st. op. Rec. Hist.No. Site. Side. Hosp. group
356. Iff. 49
357* F
35$.
359* F
360,
361. F
362. F
363. F
364.
365.
366.
367. F
368.
369. Iff
370. F
371. M
bb
73
52
47
70
62
30
69
46
76
27
64
50
51
50
69
73
52
48
71
63
31
70
52
76
31
67
65
52
53
+ Law/50 P L
+ 873/41 P R
+ L1679/50 P L
+ 586/40 P R
+ C54/46 P .R
/40 P R
262/55 P L
- HR544212 Sx
+ A1738/^3 P
+ 1796/38 P
+ P551573 P R
+ 586/40 P R
+. Law/42 Sx
/39
+ 830/52 P R
+ B /54 Pal. -
G.R.I. A. 
G.R.I.
G.R.I. -. 
G.R.I. -. 
G.R.I. B. 
G.R.I. -. 
G.R.I. A. + 
W.I.G. A. 
G.R.I. -. 
G.R.I. A. + 
W.I.G. 0. 
G.R.I. A. 
G.R.I. -. 
G.R.I. -. 
G.R.I. -. 
G.R.I. A.
Ibl.
Age at Age at Blood
Wo. Sex. onset. 1st. op. Rec. Wist.Wo. Site. Side. Hosp. group; 
r
384. P. 72 73 — law/45 Parotids.
385. M. 47 49 — HR512367 P L
386. P. 35 39 — HR501848 Parotids.
387. M. 76 77 - K /54 lonsil R
388. M. 62 64 — 1495/41 P L
389. P. 58 62 — HR5005&6 P R
390. M. 70 72 — law/44 Parotids.
391. M. 80 84 - S.G.H./55 P R
392. P. 38 41 — H / 44 Parotids.
393. P. 60 62 — HK523861 P L
394. P. 71 71 — C2385/56 P L
395. M. 60 61 3770/56 P L
iv. Miscellaneous group.
G. R. I • A. 
W.I.G. 0.
W.I.G. A.
G. R. I, A. + 
G.R.I. - 
W.I.G, A. 
G.R.I.
S.G.H. A. + 
G. R. I. A. + 
W.I.G. A3. 
G.R.I. 0. 
G.R.I. A.
163.
See over.
No. Sex. onset. 1st. op. Hec. Hist.No. & 1’ype. Site .Side .Hosp.
396. M. 52 58 + 878 /50 Leiomyosarc. P R S.G.H.
397. M. 70 70 + 261/49 Retie, sarc. P R G.R.I.
398. M.' 59 63 - 1037/46 Piteroma. P R G.R.I.
399. P. 70 72 1820/53 Retie. Sarc. Sx R G.R.I.
400. M. 52 52 +■ 1767/51 Melanoma. P R G.R.I.
401. P. 55 57 + 1602/44 Melanoma. P L G.R.I.
164.
APPENDIX IV.
Own reprint on this work already published.
Dantfet, 1.239-240 (1958)
Blood-groups in tumours of salivary tissue.
